Bronchiectasis
Researchers from Kunming, People's Republic of China, have detailed new data in Lung Diseases and Conditions - Bronchiectasis. The study collected and analyzed clinical data and lower respiratory tract pathogen detection results from 410 patients with bronchiectasis admitted to the Anning First People's Hospital Affiliated to
Bronchiectasis
A recent study published in the journal Chest has explored the effectiveness of a personalized, written bronchiectasis action management plan (BAMP) in reducing nonscheduled physician visits among children and adolescents with chronic suppurative lung disease (CSLD)/bronchiectasis. The research, conducted by investigators from Charles Darwin University, involved a multicenter, double-blind,
Bronchiectasis
Bronchiectasis is a chronic inflammatory airway disease characterized by impaired mucociliary clearance, persistent infection, and progressive structural lung damage. While inflammation is central to disease activity and progression, targeted anti-inflammatory treatments have been limited. Researchers from the Mayo Clinic have conducted a review to explore key inflammation patterns, biomarkers, and
Adults
A new study published in the Annals of the American Thoracic Society has found that symptoms measured using a validated disease-specific questionnaire can predict future exacerbation risk in patients with bronchiectasis. The research, conducted at Tongji University in Shanghai, People's Republic of China, included 436 adults with bronchiectasis
Bronchiectasis
A pilot study conducted in Karnataka, India, has investigated the effects of inhaled corticosteroids on patients with stable bronchiectasis without bronchial hyperresponsiveness. Researchers from the Department of Respiratory Medicine found that patients treated with inhaled fluticasone 500 mg twice daily for 6 months experienced a clinically significant improvement in health-related
